Functional role of connexins and pannexins in the interaction between vascular and nervous system

Journal of Cellular Physiology

Volumn 229, Issue 10, 2014, Pages 1336-1345

  Gaete, Pablo S ^a   Lillo, Mauricio A ^a   Figueroa, Xavier F ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; CALCITONIN GENE RELATED PEPTIDE RECEPTOR; CAPSAICIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GAP JUNCTION PROTEIN; MEMBRANE PROTEIN; PANNEXIN; UNCLASSIFIED DRUG;

ARTICLE; ASTROCYTE; BLOOD BRAIN BARRIER; CARDIOVASCULAR SYSTEM; ENDOTHELIUM CELL; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN SECRETION; SENSORY NERVE; SIGNAL TRANSDUCTION; VASCULARIZATION;

ANIMALS; ASTROCYTES; BLOOD-BRAIN BARRIER; CAPILLARIES; CELL COMMUNICATION; CONNEXINS; ENDOTHELIAL CELLS; HUMANS; PERIPHERAL NERVES; SIGNAL TRANSDUCTION; TIME FACTORS;

EID: 84903440603     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.24563     Document Type: Article

References (119)

1. Abbott NJ, Patabendige AA, Dolman DE, Yusof SR, Begley DJ. 2010. Structure and function of the bloodbrain barrier. Neurobiol Dis 37:13-25.
2. Ballabh P, Braun A, Nedergaard M. 2004. The bloodbrain barrier: An overview: Structure, regulation, and clinical implications. Neurobiol Dis 16:1-13.
3. Bell RD, Winkler EA, Sagare AP, Singh I, LaRue B, Deane R, Zlokovic BV. 2010. Pericytes control key neurovascular functions and neuronal phenotype in the adult brain and during brain aging. Neuron 68:409-427.
4. Billaud M, Lohman AW, Straub AC, Looft-Wilson R, Johnstone SR, Araj CA, Best AK, Chekeni FB, Ravichandran KS, Penuela S, Laird DW, Isakson BE. 2011. Pannexin1 regulates alpha1-adrenergic receptor-mediated vasoconstriction. Circ Res 109:80-85.
5. Billaud M, Sandilos JK, Isakson BE. 2012. Pannexin 1 in the regulation of vascular tone. Trends Cardiovasc Med 22:68-72.
6. Braet K, Aspeslagh S, Vandamme W, Willecke K, Martin PE, Evans WH, Leybaert L. 2003. Pharmacological sensitivity of ATP release triggered by photoliberation of inositol-1, 4, 5-trisphosphate and zero extracellular calcium in brain endothelial cells. J Cell Physiol 197:205-213.
7. Brain SD, Grant AD. 2004. Vascular actions of calcitonin gene-related peptide and adrenomedullin. Physiol Rev 84:903-934.
8. Bruzzone R, Haefliger JA, Gimlich RL, Paul DL. 1993. Connexin40, a component of gap junctions in vascular endothelium, is restricted in its ability to interact with other connexins. Mol Biol Cell 4:7-20.
9. Bruzzone R, Hormuzdi SG, Barbe MT, Herb A, Monyer H. 2003. Pannexins, a family of gap junction proteins expressed in brain. Proc Natl Acad Sci U S A 100:13644-13649.
10. 2+-regulated transmembrane NAD+ fluxes in intact cells. FASEB J 15:10-12.
11. Burns AR, Phillips SC, Sokoya EM. 2012. Pannexin protein expression in the rat middle cerebral artery. J Vasc Res 49:101-110.
12. Burnstock G. 1990. Local mechanisms of blood flow control by perivascular nerves and endothelium. J Hypertens Suppl 8:S95-S106.
13. Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD, Julius D. 1997. The capsaicin receptor: A heat-activated ion channel in the pain pathway. Nature 389:816-824.
14. Chandrasekhar A, Bera AK. 2012. Hemichannels: Permeants and their effect on development, physiology and death. Cell Biochem Funct 30:89-100.
15. Cherian PP, Siller-Jackson AJ, Gu S, Wang X, Bonewald LF, Sprague E, Jiang JX. 2005. Mechanical strain opens connexin 43 hemichannels in osteocytes: A novel mechanism for the release of prostaglandin. Mol Biol Cell 16:3100-3106.
16. Cottrell GT, Wu Y, Burt JM. 2002. Cx40 and Cx43 expression ratio influences heteromeric/heterotypic gap junction channel properties. Am J Physiol Cell Physiol 282:C1469-C1482.
17. David Y, Cacheaux LP, Ivens S, Lapilover E, Heinemann U, Kaufer D, Friedman A. 2009. Astrocytic dysfunction in epileptogenesis: Consequence of altered potassium and glutamate homeostasis?. J Neurosci 29:10588-10599.
18. Davies DC. 2002. Bloodbrain barrier breakdown in septic encephalopathy and brain tumours. J Anat 200:639-646.
19. Davis MJ, Ferrer PN, Gore RW. 1986. Vascular anatomy and hydrostatic pressure profile in the hamster cheek pouch. Am J Physiol 250:H291-H303.
20. De Bock M, Culot M, Wang N, Bol M, Decrock E, De Vuyst E, da Costa A, Dauwe I, Vinken M, Simon AM, Rogiers V, De Ley G, Evans WH, Bultynck G, Dupont G, Cecchelli R, Leybaert L. 2011. Connexin channels provide a target to manipulate brain endothelial calcium dynamics and bloodbrain barrier permeability. J Cereb Blood Flow Metab 31:1942-1957.
21. 2+ waves. Brain Res 1487:78-87.
22. De Mello WC. 1997. Influence of alpha-adrenergic-receptor activation on junctional conductance in heart cells: Interaction with beta-adrenergic adrenergic agonists. J Cardiovasc Pharmacol 29:273-277.
23. de Vries HE, Blom-Roosemalen MC, van Oosten M, de Boer AG, van Berkel TJ, Breimer DD, Kuiper J. 1996. The influence of cytokines on the integrity of the bloodbrain barrier in vitro. J Neuroimmunol 64:37-43.
24. del Zoppo GJ, Milner R. 2006. Integrinmatrix interactions in the cerebral microvasculature. Arterioscler Thromb Vasc Biol 26:1966-1975.
25. Ding J, Song D, Ye X, Liu SF. 2009. A pivotal role of endothelial-specific NF-kappaB signaling in the pathogenesis of septic shock and septic vascular dysfunction. J Immunol 183:4031-4038.
26. Dore-Duffy P. 2008. Pericytes: Pluripotent cells of the blood brain barrier. Curr Pharm Des 14:1581-1593.
27. Eltzschig HK, Eckle T, Mager A, Kuper N, Karcher C, Weissmuller T, Boengler K, Schulz R, Robson SC, Colgan SP. 2006. ATP release from activated neutrophils occurs via connexin 43 and modulates adenosine-dependent endothelial cell function. Circ Res 99:1100-1108.
28. Ervasti JM, Campbell KP. 1993. A role for the dystrophinglycoprotein complex as a transmembrane linker between laminin and actin. J Cell Biol 122:809-823.
29. Eugenin EA, Clements JE, Zink MC, Berman JW. 2011. Human immunodeficiency virus infection of human astrocytes disrupts bloodbrain barrier integrity by a gap junction-dependent mechanism. J Neurosci 31:9456-9465.
30. Evans WH, De Vuyst E, Leybaert L. 2006. The gap junction cellular internet: Connexin hemichannels enter the signalling limelight. Biochem J 397:1-14.
31. Evans WH, Martin PE. 2002. Gap junctions: Structure and function (Review). Mol Membr Biol 19:121-136.
32. Ezan P, Andre P, Cisternino S, Saubamea B, Boulay AC, Doutremer S, Thomas MA, Quenech'du N, Giaume C, Cohen-Salmon M. 2012. Deletion of astroglial connexins weakens the bloodbrain barrier. J Cereb Blood Flow Metab 32:1457-1467.
33. Figueroa XF, Duling BR. 2008. Dissection of two Cx37-independent conducted vasodilator mechanisms by deletion of Cx40: Electrotonic versus regenerative conduction. Am J Physiol Heart Circ Physiol 295:H2001-H2007.
34. Figueroa XF, Duling BR. 2009. Gap junctions in the control of vascular function. Antioxid Redox Signal 11:251-266.
35. Figueroa XF, Isakson BE, Duling BR. 2004. Connexins: Gaps in our knowledge of vascular function. Physiology (Bethesda) 19:277-284.
36. Figueroa XF, Lillo MA, Gaete PS, Riquelme MA, Saez JC. 2013. Diffusion of nitric oxide across cell membranes of the vascular wall requires specific connexin-based channels. Neuropharmacology 75:471-478.
37. Figueroa XF, Paul DL, Simon AM, Goodenough DA, Day KH, Damon DN, Duling BR. 2003. Central role of connexin40 in the propagation of electrically activated vasodilation in mouse cremasteric arterioles in vivo. Circ Res 92:793-800.
38. Filosa JA, Bonev AD, Straub SV, Meredith AL, Wilkerson MK, Aldrich RW, Nelson MT. 2006. Local potassium signaling couples neuronal activity to vasodilation in the brain. Nat Neurosci 9:1397-1403.
39. Friedman A, Kaufer D, Heinemann U. 2009. Bloodbrain barrier breakdown-inducing astrocytic transformation: Novel targets for the prevention of epilepsy. Epilepsy Res 85:142-149.
40. Gabriels JE, Paul DL. 1998. Connexin43 is highly localized to sites of disturbed flow in rat aortic endothelium but connexin37 and connexin40 are more uniformly distributed. Circ Res 83:636-643.
41. Giaume C, Marin P, Cordier J, Glowinski J, Premont J. 1991. Adrenergic regulation of intercellular communications between cultured striatal astrocytes from the mouse. Proc Natl Acad Sci U S A 88:5577-5581.
42. Giepmans BN, Moolenaar WH. 1998. The gap junction protein connexin43 interacts with the second PDZ domain of the zona occludens-1 protein. Curr Biol 8:931-934.
43. Gloor SM, Wachtel M, Bolliger MF, Ishihara H, Landmann R, Frei K. 2001. Molecular and cellular permeability control at the bloodbrain barrier. Brain Res Brain Res Rev 36:258-264.
44. Goldstein GW. 1988. Endothelial cellastrocyte interactions. A cellular model of the bloodbrain barrier. Ann N Y Acad Sci 529:31-39.
45. Goodenough DA, Paul DL. 2003. Beyond the gap: Functions of unpaired connexon channels. Nat Rev Mol Cell Biol 4:285-294.
46. Gustafsson F, Mikkelsen HB, Arensbak B, Thuneberg L, Neve S, Jensen LJ, Holstein-Rathlou NH. 2003. Expression of connexin 37, 40 and 43 in rat mesenteric arterioles and resistance arteries. Histochem Cell Biol 119:139-148.
47. Haddock RE, Grayson TH, Brackenbury TD, Meaney KR, Neylon CB, Sandow SL, Hill CE. 2006. Endothelial coordination of cerebral vasomotion via myoendothelial gap junctions containing connexins 37 and 40. Am J Physiol Heart Circ Physiol 291:H2047-H2056.
48. Haefliger JA, Nicod P, Meda P. 2004. Contribution of connexins to the function of the vascular wall. Cardiovasc Res 62:345-356.
49. Haug SJ, Segal SS. 2005. Sympathetic neural inhibition of conducted vasodilatation along hamster feed arteries: Complementary effects of alpha1- and alpha2-adrenoreceptor activation. J Physiol 563:541-555.
50. Hawkins BT, Davis TP. 2005. The bloodbrain barrier/neurovascular unit in health and disease. Pharmacol Rev 57:173-185.
51. He DS, Jiang JX, Taffet SM, Burt JM. 1999. Formation of heteromeric gap junction channels by connexins 40 and 43 in vascular smooth muscle cells. Proc Natl Acad Sci U S A 96:6495-6500.
52. Head GM, Mentlein R, von Patay B, Downing JE, Kendall MD. 1998. Neuropeptides exert direct effects on rat thymic epithelial cells in culture. Dev Immunol 6:95-104.
53. Heinemann U, Kaufer D, Friedman A. 2012. Bloodbrain barrier dysfunction, TGFbeta signaling, and astrocyte dysfunction in epilepsy. Glia 60:1251-1257.
54. Hill CE, Rummery N, Hickey H, Sandow SL. 2002. Heterogeneity in the distribution of vascular gap junctions and connexins: Implications for function. Clin Exp Pharmacol Physiol 29:620-625.
55. Huang AL, Vita JA. 2006. Effects of systemic inflammation on endothelium-dependent vasodilation. Trends Cardiovasc Med 16:15-20.
56. Iadecola C. 2004. Neurovascular regulation in the normal brain and in Alzheimer's disease. Nat Rev Neurosci 5:347-360.
57. Iadecola C, Yang G, Ebner TJ, Chen G. 1997. Local and propagated vascular responses evoked by focal synaptic activity in cerebellar cortex. J Neurophysiol 78:651-659.
58. Isakson BE, Damon DN, Day KH, Liao Y, Duling BR. 2006. Connexin40 and connexin43 in mouse aortic endothelium: Evidence for coordinated regulation. Am J Physiol Heart Circ Physiol 290:H1199-H1205.
59. 2+ and inositol 1, 4, 5-trisphosphate-mediated signaling across the myoendothelial junction. Circ Res 100:246-254.
60. Ivens S, Kaufer D, Flores LP, Bechmann I, Zumsteg D, Tomkins O, Seiffert E, Heinemann U, Friedman A. 2007. TGF-beta receptor-mediated albumin uptake into astrocytes is involved in neocortical epileptogenesis. Brain 130:535-547.
61. James M, Nguyen TM, Wise CJ, Jones GE, Morris GE. 1996. Utrophindystroglycan complex in membranes of adherent cultured cells. Cell Motil Cytoskeleton 33:163-174.
62. Kawasaki H. 2002. Regulation of vascular function by perivascular calcitonin gene-related peptide-containing nerves. Jpn J Pharmacol 88:39-43.
63. Kovacs R, Heinemann U, Steinhauser C. 2012. Mechanisms underlying bloodbrain barrier dysfunction in brain pathology and epileptogenesis: Role of astroglia. Epilepsia 53:53-59.
64. Kruger O, Beny JL, Chabaud F, Traub O, Theis M, Brix K, Kirchhoff S, Willecke K. 2002. Altered dye diffusion and upregulation of connexin37 in mouse aortic endothelium deficient in connexin40. J Vasc Res 39:160-172.
65. Kruger O, Plum A, Kim JS, Winterhager E, Maxeiner S, Hallas G, Kirchhoff S, Traub O, Lamers WH, Willecke K. 2000. Defective vascular development in connexin 45-deficient mice. Development 127:4179-4193.
66. Kuchler-Bopp S, Delaunoy JP, Artault JC, Zaepfel M, Dietrich JB. 1999. Astrocytes induce several bloodbrain barrier properties in non-neural endothelial cells. Neuroreport 10:1347-1353.
67. Kwak BR, Mulhaupt F, Veillard N, Gros DB, Mach F. 2002. Altered pattern of vascular connexin expression in atherosclerotic plaques. Arterioscler Thromb Vasc Biol 22:225-230.
68. Lai CH, Kuo KH. 2005. The critical component to establish in vitro BBB model: Pericyte. Brain Res Brain Res Rev 50:258-265.
69. Leybaert L. 2005. Neurobarrier coupling in the brain: A partner of neurovascular and neurometabolic coupling?. J Cereb Blood Flow Metab 25:2-16.
70. Li X, Simard JM. 1999. Multiple connexins form gap junction channels in rat basilar artery smooth muscle cells. Circ Res 84:1277-1284.
71. Li X, Simard JM. 2001. Connexin45 gap junction channels in rat cerebral vascular smooth muscle cells. Am J Physiol Heart Circ Physiol 281:H1890-H1898.
72. Li X, Simard JM. 2002. Increase in Cx45 gap junction channels in cerebral smooth muscle cells from SHR. Hypertension 40:940-946.
73. Liebner S, Czupalla CJ, Wolburg H. 2011. Current concepts of bloodbrain barrier development. Int J Dev Biol 55:467-476.
74. Little TL, Beyer EC, Duling BR. 1995. Connexin 43 and connexin 40 gap junctional proteins are present in arteriolar smooth muscle and endothelium in vivo. Am J Physiol 268:H729-H739.
75. Locovei S, Wang J, Dahl G. 2006. Activation of pannexin 1 channels by ATP through P2Y receptors and by cytoplasmic calcium. FEBS Lett 580:239-244.
76. Lohman AW, Billaud M, Straub AC, Johnstone SR, Best AK, Lee M, Barr K, Penuela S, Laird DW, Isakson BE. 2012. Expression of pannexin isoforms in the systemic murine arterial network. J Vasc Res 49:405-416.
77. Looft-Wilson RC, Haug SJ, Neufer PD, Segal SS. 2004. Independence of connexin expression and vasomotor conduction from sympathetic innervation in hamster feed arteries. Microcirculation 11:397-408.
78. Lossinsky AS, Shivers RR. 2004. Structural pathways for macromolecular and cellular transport across the bloodbrain barrier during inflammatory conditions. Review. Histol Histopathol 19:535-564.
79. Martinez AD, Hayrapetyan V, Moreno AP, Beyer EC. 2002. Connexin43 and connexin45 form heteromeric gap junction channels in which individual components determine permeability and regulation. Circ Res 90:1100-1107.
80. Miller E. 2012. Multiple sclerosis. Adv Exp Med Biol 724:222-238.
81. Moreno AP. 2004. Biophysical properties of homomeric and heteromultimeric channels formed by cardiac connexins. Cardiovasc Res 62:276-286.
82. Mulvany MJ, Aalkjaer C. 1990. Structure and function of small arteries. Physiol Rev 70:921-961.
83. Nagasawa K, Chiba H, Fujita H, Kojima T, Saito T, Endo T, Sawada N. 2006. Possible involvement of gap junctions in the barrier function of tight junctions of brain and lung endothelial cells. J Cell Physiol 208:123-132.
84. Okamoto T, Akiyama M, Takeda M, Gabazza EC, Hayashi T, Suzuki K. 2009. Connexin32 is expressed in vascular endothelial cells and participates in gapjunction intercellular communication. Biochem Biophys Res Commun 382:264-268.
85. Orellana JA, Figueroa XF, Sanchez HA, Contreras-Duarte S, Velarde V, Saez JC. 2011. Hemichannels in the neurovascular unit and white matter under normal and inflamed conditions. CNS Neurol Disord Drug Targets 10:404-414.
86. Panchin Y, Kelmanson I, Matz M, Lukyanov K, Usman N, Lukyanov S. 2000. A ubiquitous family of putative gap junction molecules. Curr Biol 10:R473-R474.
87. Perkins GA, Goodenough DA, Sosinsky GE. 1998. Formation of the gap junction intercellular channel requires a 30 degree rotation for interdigitating two apposing connexons. J Mol Biol 277:171-177.
88. Piao H, Sato A, Nozawa Y, Sun W, Morioka T, Oite T. 2011. Effects of connexin-mimetic peptides on perfusion pressure in response to phenylephrine in isolated, perfused rat kidneys. Clin Exp Nephrol 15:203-211.
89. Rolfe DF, Brown GC. 1997. Cellular energy utilization and molecular origin of standard metabolic rate in mammals. Physiol Rev 77:731-758.
90. Rubino A, Burnstock G. 1996. Capsaicin-sensitive sensory-motor neurotransmission in the peripheral control of cardiovascular function. Cardiovasc Res 31:467-479.
91. Rummery NM, Hickey H, McGurk G, Hill CE. 2002a. Connexin37 is the major connexin expressed in the media of caudal artery. Arterioscler Thromb Vasc Biol 22:1427-1432.
92. Rummery NM, McKenzie KU, Whitworth JA, Hill CE. 2002b. Decreased endothelial size and connexin expression in rat caudal arteries during hypertension. J Hypertens 20:247-253.
93. Saez JC, Berthoud VM, Branes MC, Martinez AD, Beyer EC. 2003. Plasma membrane channels formed by connexins: Their regulation and functions. Physiol Rev 83:1359-1400.
94. Sandow SL, Looft-Wilson R, Doran B, Grayson TH, Segal SS, Hill CE. 2003. Expression of homocellular and heterocellular gap junctions in hamster arterioles and feed arteries. Cardiovasc Res 60:643-653.
95. Segal SS. 2000. Integration of blood flow control to skeletal muscle: Key role of feed arteries. Acta Physiol Scand 168:511-518.
96. Segal SS. 2005. Regulation of blood flow in the microcirculation. Microcirculation 12:33-45.
97. Seiffert E, Dreier JP, Ivens S, Bechmann I, Tomkins O, Heinemann U, Friedman A. 2004. Lasting bloodbrain barrier disruption induces epileptic focus in the rat somatosensory cortex. J Neurosci 24:7829-7836.
98. Severs NJ, Rothery S, Dupont E, Coppen SR, Yeh HI, Ko YS, Matsushita T, Kaba R, Halliday D. 2001. Immunocytochemical analysis of connexin expression in the healthy and diseased cardiovascular system. Microsc Res Tech 52:301-322.
99. Simon AM, McWhorter AR. 2002. Vascular abnormalities in mice lacking the endothelial gap junction proteins connexin37 and connexin40. Dev Biol 251:206-220.
100. Sorkin LS, Xiao WH, Wagner R, Myers RR. 1997. Tumour necrosis factor-alpha induces ectopic activity in nociceptive primary afferent fibres. Neuroscience 81:255-262.
101. Spindler KR, Hsu TH. 2012. Viral disruption of the bloodbrain barrier. Trends Microbiol 20:282-290.
102. Stout CE, Costantin JL, Naus CC, Charles AC. 2002. Intercellular calcium signaling in astrocytes via ATP release through connexin hemichannels. J Biol Chem 277:10482-10488.
103. Teubner B, Michel V, Pesch J, Lautermann J, Cohen-Salmon M, Sohl G, Jahnke K, Winterhager E, Herberhold C, Hardelin JP, Petit C, Willecke K. 2003. Connexin30 (Gjb6)-deficiency causes severe hearing impairment and lack of endocochlear potential. Hum Mol Genet 12:13-21.
104. Theis M, Mas C, Doring B, Kruger O, Herrera P, Meda P, Willecke K. 2001. General and conditional replacement of connexin43-coding DNA by a lacZ reporter gene for cell-autonomous analysis of expression. Cell Commun Adhes 8:383-386.
105. Thompson RJ, Macvicar BA. 2008. Connexin and pannexin hemichannels of neurons and astrocytes. Channels (Austin) 2:81-86.
106. Tomkins O, Friedman O, Ivens S, Reiffurth C, Major S, Dreier JP, Heinemann U, Friedman A. 2007. Bloodbrain barrier disruption results in delayed functional and structural alterations in the rat neocortex. Neurobiol Dis 25:367-377.
107. Tomkins O, Shelef I, Kaizerman I, Eliushin A, Afawi Z, Misk A, Gidon M, Cohen A, Zumsteg D, Friedman A. 2008. Bloodbrain barrier disruption in post-traumatic epilepsy. J Neurol Neurosurg Psychiatry 79:774-777.
108. Toyofuku T, Yabuki M, Otsu K, Kuzuya T, Hori M, Tada M. 1998. Direct association of the gap junction protein connexin-43 with ZO-1 in cardiac myocytes. J Biol Chem 273:12725-12731.
109. Tsuru H, Tanimitsu N, Hirai T. 2002. Role of perivascular sympathetic nerves and regional differences in the features of sympathetic innervation of the vascular system. Jpn J Pharmacol 88:9-13.
110. Ujiie H, Chaytor AT, Bakker LM, Griffith TM. 2003. Essential role of Gap junctions in NO- and prostanoid-independent relaxations evoked by acetylcholine in rabbit intracerebral arteries. Stroke 34:544-550.
111. Unger VM, Kumar NM, Gilula NB, Yeager M. 1999. Three-dimensional structure of a recombinant gap junction membrane channel. Science 283:1176-1180.
112. van Kempen MJ, Jongsma HJ. 1999. Distribution of connexin37, connexin40 and connexin43 in the aorta and coronary artery of several mammals. Histochem Cell Biol 112:479-486.
113. van Kempen MJ, ten Velde I, Wessels A, Oosthoek PW, Gros D, Jongsma HJ, Moorman AF, Lamers WH. 1995. Differential connexin distribution accommodates cardiac function in different species. Microsc Res Tech 31:420-436.
114. Virgintino D, Robertson D, Errede M, Benagiano V, Bertossi M, Ambrosi G, Roncali L. 2001. Expression of the gap junction protein connexin43 in human telencephalon microvessels. Microvasc Res 62:435-439.
115. Wachtel M, Bolliger MF, Ishihara H, Frei K, Bluethmann H, Gloor SM. 2001. Down-regulation of occludin expression in astrocytes by tumour necrosis factor (TNF) is mediated via TNF type-1 receptor and nuclear factor-kappaB activation. J Neurochem 78:155-162.
116. Wang X, Wu Z, Tang Y, Fiscus RR, Han C. 1996. Rapid nitric oxide- and prostaglandin-dependent release of calcitonin gene-related peptide (CGRP) triggered by endotoxin in rat mesenteric arterial bed. Br J Pharmacol 118:2164-2170.
117. Wood JN, Docherty R. 1997. Chemical activators of sensory neurons. Annu Rev Physiol 59:457-482.
118. Yoshizumi M, Perrella MA, Burnett JC, Jr., Lee ME. 1993. Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life. Circ Res 73:205-209.
119. Zygmunt PM, Petersson J, Andersson DA, Chuang H, Sorgard M, Di Marzo V, Julius D, Hogestatt ED. 1999. Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature 400:452-457.